Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v9-EN Version v8-FR
Language English French
Date Updated 2020-04-02 2020-04-01
Drug Identification Number 02332957 02332957
Brand name ATACAND PLUS ATACAND PLUS
Common or Proper name candesartan cilexetil and hydrochlorothiazide candesartan cilexetil and hydrochlorothiazide
Company Name CHEPLAPHARM ARZNEIMITTEL GMBH CHEPLAPHARM ARZNEIMITTEL GMBH
Ingredients HYDROCHLOROTHIAZIDE CANDESARTAN CILEXETIL HYDROCHLOROTHIAZIDE CANDESARTAN CILEXETIL
Strength(s) 25MG 32MG 25MG 32MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL
Packaging size 30 tablets 30 tablets
ATC code C09DA C09DA
ATC description ANGIOTENSIN II ANTAGONISTS, COMBINATIONS ANGIOTENSIN II ANTAGONISTS, COMBINATIONS
Reason for shortage Demand increase for the drug. Demand increase for the drug.
Anticipated start date 2020-03-24 2020-03-24
Actual start date 2020-03-24 2020-03-24
Estimated end date 2020-04-17 2020-04-17
Actual end date 2020-04-01 2020-04-01
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments
Health Canada comments